# 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT

> **NCT00767481** · PHASE3 · TERMINATED · sponsor: **Alcon Research** · enrollment: 6 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost/Brinzolamide
- **DRUG:** Cosopt

## Key facts

- **NCT ID:** NCT00767481
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Project Cancelled
- **Last updated:** 2012-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767481, "1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00767481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*